一种用于预测 COVID-19 疾病严重程度的新型评分系统。
A Novel Scoring System for Prediction of Disease Severity in COVID-19.
机构信息
Beijing You'an Hospital, Capital Medical University, Beijing, China.
Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford, Oxford, United Kingdom.
出版信息
Front Cell Infect Microbiol. 2020 Jun 5;10:318. doi: 10.3389/fcimb.2020.00318. eCollection 2020.
A novel enveloped RNA beta coronavirus, Corona Virus Disease 2019 (COVID-19) caused severe and even fetal pneumonia in China and other countries from December 2019. Early detection of severe patients with COVID-19 is of great significance to shorten the disease course and reduce mortality. We assembled a retrospective cohort of 80 patients (including 56 mild and 24 severe) with COVID-19 infection treated at Beijing You'an Hospital. We used univariable and multivariable logistic regression analyses to select the risk factors of severe and even fetal pneumonia and build scoring system for prediction, which was validated later on in a group of 22 COVID-19 patients. Age, white blood cell count, neutrophil, glomerular filtration rate, and myoglobin were selected by multivariate analysis as candidates of scoring system for prediction of disease severity in COVID-19. The scoring system was applied to calculate the predictive value and found that the percentage of ICU admission (20%, 6/30) and ventilation (16.7%, 5/30) in patients with high risk was much higher than those (2%, 1/50; 2%, 1/50) in patients with low risk ( = 0.009; = 0.026). The AUC of scoring system was 0.906, sensitivity of prediction is 70.8%, and the specificity is 89.3%. According to scoring system, the probability of patients in high risk group developing severe disease was 20.24 times than that in low risk group. The possibility of severity in COVID-19 infection predicted by scoring system could help patients to receiving different therapy strategies at a very early stage. COVID-19, severe and fetal pneumonia, logistic regression, scoring system, prediction.
一种新型包膜 RNA β 冠状病毒,即 2019 年冠状病毒病(COVID-19),自 2019 年 12 月以来在中国和其他国家引发了严重甚至胎儿肺炎。早期发现 COVID-19 重症患者对于缩短病程和降低死亡率具有重要意义。我们回顾性收集了北京佑安医院收治的 80 例 COVID-19 感染患者(包括 56 例轻症和 24 例重症)的临床资料。我们采用单因素和多因素逻辑回归分析筛选 COVID-19 重症及胎儿肺炎的危险因素,并建立预测评分系统,随后在 22 例 COVID-19 患者中进行验证。多因素分析选择年龄、白细胞计数、中性粒细胞、肾小球滤过率和肌红蛋白作为预测 COVID-19 疾病严重程度评分系统的候选因素。评分系统用于计算预测价值,发现高危患者的 ICU 入住率(20%,6/30)和通气率(16.7%,5/30)明显高于低危患者(2%,1/50;2%,1/50;=0.009;=0.026)。评分系统的 AUC 为 0.906,预测的敏感度为 70.8%,特异性为 89.3%。根据评分系统,高危组患者发生重症疾病的概率是低危组的 20.24 倍。评分系统预测 COVID-19 感染严重程度的可能性有助于患者在早期接受不同的治疗策略。COVID-19,重症和胎儿肺炎,逻辑回归,评分系统,预测。